Phosphoramidite for incorporation of cholesterol at 5' end of an oligonucleotide, with a triethylene glycol spacer.
Methoxy-protected phosphoramidite for incorporation of a 5′-(E)-Vinylphosphonate (VP) moiety into an oligonucleotide.
POM-protected phosphoramidite for incorporation of a 5′-(E)-Vinylphosphonate (VP) moiety into an oligonucleotide.
Phosphoramidite used to incorporate a lipophilic palmitoyl-modifier at the 5' end of an oligonucleotide.
Phosphoramidite used to incorporate a tocopherol modification at the 5' end of an oligonucleotide.
Phosphoramidite for incorporation of cholesterol at 5' end of an oligonucleotide, with an all-carbon spacer.
Phosphoramidite used to incorporate a tocopherol modification at the 5' end of an oligonucleotide, with a C8 spacer.
Phosphoramidite for N-Acetylgalactosamine (GalNAc) incorporation in an oligonucleotide.
Phosphoramidite for the incorporation of a 2’-O-hexadecyl lipophilic chain-modified adenosine internally or at the 5' end of an oligonucleotide.
Phosphoramidite for the incorporation of a lipophilic dodecanoic chain internally or at the 5' end of an oligonucleotide, with a C7 spacer.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |
